HIGHLIGHTS
- who: Marios Sagris et al. from the rd Department of Cardiology, "Sotiria" Thoracic Diseases Hospital of Athens, University of Athens Medical School, , Athens, Greece have published the research work: Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?, in the Journal: Biomedicines 2022, 10, x. of 30/01/2020
- what: SARS-CoV-2 and the resulting catastrophic outcomes due to the endothelial activation, which result Genetic predisposition, as in other COVID-19 have led to a global pandemic with induced hyperinflammatory state and systemic in pulmonary and cardiovascular complications. inflammatory diseases, might . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.